Address Confusion About Biosimilars

You'll see a growing list of biosimilars.

Nivestym or Zarxio for Neupogen (filgrastim)...Fulphila for Neulasta (pegfilgrastim)...and Inflectra or Renflexis for Remicade (infliximab).

Biosimilars are also approved for Enbrel, Humira, Avastin, and others...but aren't yet available due to legal disputes or other issues.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote